Maraviroc, CCR5 anatagonist, influences the activation of various signaling pathways and exhibits an analgesic in rat model of neuropathy -in vivo and in vitro studies
Authors: Piotrowska-Murzyn A., Kwiatkowski K., Rojewska E., Makuch W., Jurga AM., Ślusarczyk J., Trojan E., Basta-Kaim A., Mika J.
Published in: 6th International Congress on Neuropathic Pain, Wydawca:NEUPSIG, Goteborg
Publication type: conference